Health

World Contraception Day 2023: Bayer Indonesia launches "Bayer For Her" to improve the reproductive health of Indonesian women

Bayer promotes the empowerment of Indonesian women, enabling them to make informed choices on their reproductive health to enhance a better quality of life. JAKARTA, Indonesia, Sept. 26, 2023 /PRNewswire/ -- Coinciding with the commemoration of World Contraception Day 2023, Bayer Indonesia launc...

2023-09-26 16:56 2190

LONGi reduces the number of people lacking electricity and facilitates energy equity to keep the world with disparities in harmony empowered by light

GENEVA, Sept. 26, 2023 /PRNewswire/ -- Lebanon faces an acute shortage of electricity, and consequently private generators have become a ubiquitous presence on the streets of the country since the 1990s. AL Zaharaa Hospital, one of the largest hospitals inLebanon, is a comprehensive hospital inte...

2023-09-26 14:49 1669

Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

--Based on prespecified interim analysis condition, 120 patients are likely to lead sufficient events for interim analysis of progression-free survival (PFS) HANGZHOU and SHAOXING, China, Sept. 26, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the completion o...

2023-09-26 08:10 2156

Recommended Souvenir from Korea, Jung Kwan Jang Red Ginseng

SEOUL, South Korea, Sept. 26, 2023 /PRNewswire/ -- KGC(Korea Ginseng Corp.) promotes newly launched "Korean Red Ginseng Extract Everytime Film" as the most recommended souvenir from Korea. A high volume of sales with 130,000 units were sold within a mere month of its launch this summer due to its...

2023-09-26 08:00 4646

Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help Transform Singapore's Life Science Innovation Ecosystem

The first-of-its-kind collaboration will embed the services and resources of Johnson & Johnson Innovation - JLABS intoSingapore's life science ecosystem to unlock regional innovation potential. SINGAPORE, Sept. 26, 2023 /PRNewswire/ -- Johnson & Johnson International ( Singapore) Pte. Ltd. today ...

2023-09-26 06:30 2382

The 88th CMEF in Shenzhen Set to Spotlight Advancements in the Medical Equipment Industry

SHENZHEN, China, Sept. 25, 2023 /PRNewswire/ -- The China International Medical Equipment Fair (CMEF), organized by Reed Sinopharm Exhibitions, serves as an excellent bridge for brands aiming to enter the Chinese market. The 88th edition of this prestigious medical event is scheduled to take plac...

2023-09-25 21:00 3352

EQT PRIVATE EQUITY TO SELL LIMACORPORATE TO ENOVIS: THE ITALIAN SITE IN SAN DANIELE DEL FRIULI WILL REMAIN THE FULCRUM OF PRODUCTION, BENEFITING FROM NEW INVESTMENTS

UDINE, Italy, Sept. 25, 2023 /PRNewswire/ -- EQT Private Equity announces the sale of LimaCorporate to Enovis. With this transaction, LimaCorporate will become part of the NYSE-listed Enovis group in a strategic combination that creates a global leader in the orthopaedic industry. Founded in 194...

2023-09-25 18:01 2060

Huawei Accelerates Intelligent Healthcare with the Innovative Digital Medical Technology Solution

SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- During HUAWEI CONNECT 2023, Huawei held the first intelligent healthcare summit themed "Build a Digital Health Community to Accelerate Intelligent Healthcare". Huawei released the Digital Medical Technology Solution to help the healthcare industry go smart...

2023-09-25 15:35 2188

"Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery"

SHENZHEN, China, Sept. 25, 2023 /PRNewswire/ -- On September 15, "Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery" successfully kicked off. This marks the first time in recent years that the Company has organized an event specifically focused on pharmaceutical R&D innovation. The...

2023-09-25 15:31 2090

Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology

CASTRES, France and CAMBRIDGE, England, Sept. 25, 2023 /PRNewswire/ -- Pierre Fabre Laboratories and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology targets.   ...

2023-09-25 15:00 1521

Power Up with Energizer's Re-Energize 100% Fitfest this October

Open For Individuals Aged 13 And Above, The 3-Day Fitness-Packed Fest Is Now Open For Registration And Give Your Car The Finish It Deserves At Armor All Carwash Section KUALA LUMPUR, Malaysia, Sept. 25, 2023 /PRNewswire/ -- Energizer Malaysia announcesRe-Energize 100% Fitfest, a power-packed fit...

2023-09-25 11:48 2112

'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia

* Bridging the gap on lack of discussion amongst Asian women on their health concerns this World Contraception Day (WCD) SINGAPORE, Sept. 25, 2023  /PRNewswire/ -- Bayer Pharmaceuticals Division inAsia/Pacific announced today in conjunction with World Contraception Day, the inception of its 'Ba...

2023-09-25 09:56 2343

AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD

SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychi...

2023-09-25 09:00 2492

ASTRAZENECA AND INSTITUT KANSER NEGARA PARTNER TO INTRODUCE AI TECHNOLOGY FOR LUNG SCREENING

The partnership paves the way for the adoption of AI technology in chest x-ray for early lung screening at government health facilities KUALA LUMPUR, Malaysia, Sept. 22, 2023 /PRNewswire/ -- In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaborat...

2023-09-25 09:00 2951

Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC

SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody independently developed by the company, in combination with drugs...

2023-09-25 07:41 2031

Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility

SALT LAKE CITY, Sept. 22, 2023 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 100,000-square-foot expansion of their operations inBrooklyn Park, Minnesota, bringing the facility ...

2023-09-22 22:03 2130

The UNICEF Charity Run 2023 Hosted Runners Calling Ceremony

Registration Closing Soon and Calling on Everyone to Run for Every Child! HONG KONG, Sept. 22, 2023 /PRNewswire/ -- UNICEF Charity Run 2023, the largest charity road race event inHong Kong, will be held on the 5th of November this year at Hong Kong Disneyland Resort andSunny Bay. A Runners Calli...

2023-09-22 13:42 2029

BRACCO IMAGING S.p.A. ANNOUNCES GLOBAL AGREEMENT WITH SUBTLE MEDICAL, Inc.

Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI MILAN, Sept. 21, 2023 /PRNewswire/ -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a leading innovator in artificial intelligence (AI)-powered image acquisition, have entered into a...

2023-09-21 22:00 2970

New Wacom Signature Displays expand digital signature capture options for healthcare, financial services and transaction management

HONG KONG, Sept. 21, 2023 /PRNewswire/ -- Wacom announces its new Signature Displays the 13 touch (DTH134) and 12 (DTC121), a new eDocument solution enabling digital transformation initiatives. With an extremely simple, plug-and-play single cable connection, the Wacom Signature Displays enable a...

2023-09-21 18:45 4078

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

- The Phase I "PERFORM" study will evaluate the safety and tolerability, pharmacology, immunogenicity, and preliminary efficacy of ATG-031 in patients with advanced solid tumors or B-cell non-Hodgkin's lymphoma (B-NHL).   - ATG-031,discovered and developed in-house by Antengene,is the world's firs...

2023-09-21 18:05 2122
1 ... 122123124125126127128 ... 582